Breaking News, Promotions & Moves

BioDuro-Sundia Appoints Dr. Armin Spura as CEO

Spura brings over two decades of experience in the life sciences and biotechnology sectors.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

BioDuro-Sundia, a Contract Research, Development, and Manufacturing Organization (CRDMO), has appointed Dr. Armin Spura as its new Chief Executive Officer.
 
Spura brings over two decades of experience in the life sciences and biotechnology sectors, with a proven track record of driving growth and innovation across global markets.
 
Spura joins BioDuro-Sundia from Crown Bioscience, where he served as the CEO for nearly five years, guiding the company through significant growth and strategic development. Throughout his career, he has held senior leadership positions at several well-known organizations such as Thermo Fisher Scientific, WuXi NEXTCODE, CareDx and Ion Torrent. He also holds various advisory roles, serving as the chair of the board of directors for SeromYx Systems and as a life science investment advisor at K2X Technology and Life Science.
 
Early in his career, Spura helped to grow two start-up companies: Ingenuity Systems (acquired by Qiagen) and ForteBio (now part of Danaher). He studied biochemistry in Germany and received his Ph.D. in molecular biology from Brown University in the U.S.
 
“I am honored to join BioDuro-Sundia and lead this talented team as we embark on the next phase of growth,” said Spura. “With our unique, fully integrated CRDMO platform — encompassing chemistry, biology, DMPK, drug substance, and drug product from discovery through to commercial manufacturing — I am confident we will empower more partners to bring better treatments to patients around the world faster.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters